[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "solid tumor",
            "mesothelioma",
            "TP53"
        ],
        "dcp_id": null,
        "interventional_model": "Single Group",
        "lead_org": "Astex Pharmaceuticals, Inc.",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Inclusion Criteria:\r\n\r\n        Age\r\n\r\n          1. Participant must be 18 years of age or older, at the time of signing the informed\r\n             consent.\r\n\r\n             Type of Participant and Disease Characteristics\r\n\r\n          2. Have histologically or cytologically confirmed advanced solid tumors that are\r\n             metastatic or unresectable and are refractory or have relapsed after treatment with\r\n             standard available therapies or for whom standard life-prolonging measures are not\r\n             available.\r\n\r\n               1. Phase 1: any tumor type is eligible\r\n\r\n               2. Phase 2: eligible tumor types as follows: malignant pleural mesothelioma (MPM)\r\n                  (Cohort 1); sarcomas with human murine double minute 2 (MDM2) amplification\r\n                  (Cohort 2); any solid tumors with CDNK2A loss (Cohort 3); any solid tumors with\r\n                  molecular feature that may confer sensitivity to ASTX295 (Cohort 4).\r\n\r\n          3. Documented wild-type TP53 gene status.\r\n\r\n          4. Have an Eastern Cooperative Oncology Group (ECOG) Performance status (PS) of 0 to 2.\r\n\r\n          5. Acceptable bone marrow function, as evidenced by the following laboratory data:\r\n\r\n               1. Absolute neutrophil count (ANC) \u22651500 cells/mm3\r\n\r\n               2. Platelet count \u2265100,000 cells/mm3\r\n\r\n               3. Hemoglobin >9 g/dL\r\n\r\n          6. Adequate hepatic function as evidenced by:\r\n\r\n               1. Serum total bilirubin \u22641.5 \u00d7 upper limit of normal (ULN).\r\n\r\n               2. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) \u22642.5 \u00d7 ULN (\u2264\r\n                  3 ULN in the presence of liver metastases).\r\n\r\n               3. Serum creatinine \u22641.5 \u00d7 ULN OR calculated creatinine clearance (by the standard\r\n                  Cockcroft-Gault formula) of \u226550 mL/min or measured glomerular filtration rate of\r\n                  \u226550 mL/min.\r\n\r\n             Sex\r\n\r\n          7. Participant can be male or female\r\n\r\n             Informed Consent\r\n\r\n          8. Capable of giving signed informed consent, which includes compliance with the\r\n             requirements and restrictions listed in the informed consent form (ICF) and in this\r\n             protocol, and willing to participate in the study.\r\n\r\n             Participants are eligible to be included in Phase 1 Part B of the study only if all of\r\n             the following additional criteria apply:\r\n\r\n          9. In Phase 1 Part B (dose expansion) of the protocol, subjects must have disease lesions\r\n             that are amenable to biopsy and must agree and be able to undergo a pre- and on-\r\n             treatment biopsy.\r\n\r\n             Participants are eligible to be included in Phase 2 of the study only if all of the\r\n             following additional criteria apply:\r\n\r\n         10. There is confirmed availability of sufficient tumor specimen either from archival\r\n             formalin-fixed, paraffin embedded (FFPE) tissue or tissue obtained by a fresh biopsy\r\n             for analyzing TP53 at a central laboratory.\r\n\r\n         11. Measurable disease according to appropriate criteria as per protocol.\r\n\r\n        Exclusion Criteria:\r\n\r\n        Medical Conditions\r\n\r\n          1. Poor medical risk in the investigator's opinion because of systemic diseases in\r\n             addition to the cancer under study, for example, uncontrolled infections.\r\n\r\n          2. Life-threatening illness, significant organ system dysfunction, or other condition\r\n             that, in the investigator's opinion, could compromise subject safety, or the integrity\r\n             of study outcomes, or interfere with the absorption or metabolism of ASTX295.\r\n\r\n          3. History of, or at risk for, cardiac disease, as evidenced by any of the following\r\n             conditions:\r\n\r\n               1. Abnormal left ventricular ejection fraction.\r\n\r\n               2. Congestive cardiac failure of \u2265Grade 3.\r\n\r\n               3. Unstable cardiac disease.\r\n\r\n               4. History or evidence at Screening of long QT interval corrected for heart rate\r\n                  (QTcF), ventricular arrhythmias, clinically significant bradyarrhythmias,\r\n                  third-degree atrioventricular (AV) block, presence of cardiac pacemaker or\r\n                  defibrillator, or other clinically significant arrhythmias.\r\n\r\n               5. Screening 12-lead electrocardiogram (ECG) with measurable QTcF interval of \u2265470\r\n                  msec. (Fridericia's formula should be used).\r\n\r\n          4. Known advanced human immunodeficiency virus (HIV) infection (including AIDS): clinical\r\n             stage \u2265 3 according to WHO classification and/or HIV-associated immunodeficiency (CD4\r\n             count less than 500 per mm3 of blood). Antiretroviral therapy (ART) is allowed\r\n             (subjects should be on established ART for at least four weeks and have an HIV viral\r\n             load less than 400 copies/mL prior to enrollment).\r\n\r\n          5. Active hepatitis B virus (HBV) or active hepatitis C virus (HCV) infection (Inactive\r\n             Hepatitis Carrier and subjects with laboratory evidence of no active replication on\r\n             antivirals - viral load below limit of detection- will be permitted).\r\n\r\n          6. Known brain metastases, unless previously treated and clinically stable for at least 4\r\n             weeks with or without steroids.\r\n\r\n          7. Known significant mental illness or other conditions, such as active alcohol or other\r\n             substance abuse that, in the opinion of the investigator, predispose the subject to\r\n             high risk of noncompliance with the protocol treatment or assessments.\r\n\r\n             Prior/Concomitant Therapy\r\n\r\n          8. Prior anticancer treatments or therapies within the indicated time window prior to\r\n             first dose of study treatment (ASTX295), as follows:\r\n\r\n               1. Cytotoxic chemotherapy within 3 weeks prior. Any encountered treatment-related\r\n                  toxicities (excepting alopecia) must be stabilized or resolved to \u2264Grade 1.\r\n\r\n               2. Monoclonal antibodies, biologics, or immunotherapy within 4 weeks prior. Any\r\n                  encountered treatment-related toxicities must be stabilized or resolved to \u2264Grade\r\n                  1.\r\n\r\n               3. Molecularly targeted drug or other investigational drugs, without the potential\r\n                  for delayed toxicity, within 4 weeks of the first dose of study treatment or 5\r\n                  half-lives (minimum 14 days), whichever is shorter. Any encountered\r\n                  treatment-related toxicities must be stabilized or resolved to \u2264Grade 1.\r\n\r\n               4. Major surgery or radiation within 4 weeks prior to first dose (palliative\r\n                  radiotherapy to a single lesion within 2 weeks).\r\n\r\n          9. Prior treatment with MDM2 antagonist\r\n\r\n         10. Inability to swallow oral medication or inability or unwillingness to comply with the\r\n             administration requirements related to ASTX295.\r\n\r\n             Participants are excluded from the Phase 2 part of the study if any of the following\r\n             additional criteria apply:\r\n\r\n         11. Active malignancy other than the cancer under study (excludes low risk prostate\r\n             cancer, basal cell carcinoma of the skin and superficial bladder cancer)."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "ASTX295 is a synthetic small molecule that acts as an antagonist of Murine Double Minute 2\r\n      (MDM2; human homolog also known as HDM2). Study ASTX295-01 is a Phase 1/2 first in human\r\n      (FIH) study with ASTX295 in subjects who are refractory or have relapsed after treatment with\r\n      standard of care therapies, or for whom standard life-prolonging measures or approved\r\n      therapies are not available.\r\n\r\n      Phase 1 is composed of Phase 1a and 1b, a dose escalation stage followed by a dose expansion\r\n      stage, respectively. Phase 1 is intended to identify the recommended dose for expansion (RDE)\r\n      and ultimately the recommended Phase 2 dose (RP2D).",
        "official_title": "Phase 1/2 Open-Label Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX295 in Subjects With Wild-Type TP53 Advanced Solid Tumors",
        "_phase_sort_order": 3,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Blood will be collected during Cycles 1 and 2 on Days 1 and 2 (each cycle is 28 days)",
                "name": "Pharmacokinetic (PK) profile of ASTX295 (area under the curve [AUC])",
                "description": "ASTX295 plasma concentration AUC; fed and fasted in Phase 1; fasted in Phase 2",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Blood will be collected during Cycles 1 and 2 on Days 1 and 2 (each cycle is 28 days)",
                "name": "Pharmacokinetic (PK) profile of ASTX295 (elimination half-life [t\u00bd])",
                "description": "The elimination half-life (t\u00bd) of ASTX295 in plasma; fed and fasted in Phase 1; fasted in Phase 2",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Blood will be collected during Cycles 1 and 2 on Days 1 and 2 (each cycle is 28 days)",
                "name": "Pharmacokinetic (PK) profile of ASTX295 (maximum concentration [Cmax])",
                "description": "ASTX295 plasma maximum concentration; fed and fasted in Phase 1; fasted in Phase 2",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Blood will be collected during Cycles 1 and 2 on Days 1 and 2 (each cycle is 28 days)",
                "name": "Pharmacokinetic (PK) profile of ASTX295 (minimum concentration [Cmin])",
                "description": "ASTX295 plasma minimum concentration; fed and fasted in Phase 1; fasted in Phase 2",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Blood will be collected during Cycles 1 and 2 on Days 1 and 2 (each cycle is 28 days)",
                "name": "Pharmacokinetic (PK) profile of ASTX295 (time to reach maximum concentration [Tmax])",
                "description": "The time to reach maximum concentration of ASTX295 in plasma; fed and fasted in Phase 1; fasted in Phase 2",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From the date of the first dose until 30 days after discontinuation of study treatment",
                "name": "Phase 1a: Safety and tolerability of ASTX295 including determination of maximum tolerated dose (MTD), and/or recommended dose for expansion (RDE) to Phase 1b",
                "description": "The safety and tolerability will be based on incidence and severity of treatment-emergent adverse events (AEs) including serious adverse events (SAEs) and dose limiting toxicities (DLTs)",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "From the date of the first dose until 30 days after discontinuation of study treatment, an average of 6 months to 1 year",
                "name": "Phase 1b: Recommended Phase 2 dose (RP2D) and regimen of ASTX295 to proceed to Phase 2",
                "description": "The RP2D will be based on incidence and severity of AEs, including SAEs and will be determined by the data and safety review committee (DSRC)",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "From the date of the first dose until study treatment discontinuation, an average of 6 months to 1 year",
                "name": "Phase 1: Preliminary clinical activity as assessed by objective response rate (ORR) of ASTX295",
                "description": "ORR will be calculated as the number of subjects whose best response is CR or PR, divided by the total number of subjects evaluable for ORR analysis",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From the date of the first dose until Week 16",
                "name": "Phase 1: Preliminary clinical activity of ASTX295 as assessed by disease control rate (DCR)",
                "description": "DCR will be calculated as the number of subjects whose response at Week 16 is CR, PR, or stable disease, divided by the total number of subjects evaluable for DCR analysis",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From the date of the first dose until Week 16",
                "name": "Phase 2: Disease control rate (DCR) in Cohort 1",
                "description": "DCR will be calculated in Cohort 1 as the number of subjects whose response at Week 16 is CR, partial response (PR), or stable disease, divided by the total number of subjects evaluable for DCR analysis.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "From the date of the first dose until study treatment discontinuation, an average of 6 months to 1 year",
                "name": "Phase 2: Overall response rate (ORR) in Cohort 1",
                "description": "ORR in Cohort 1 will be calculated as the number of subjects whose best response is CR or PR, divided by the total number of subjects evaluable for ORR analysis.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From the date of the first dose until study treatment discontinuation, an average of 6 months to 1 year",
                "name": "Phase 2: Overall response rate (ORR) in Cohorts 2, 3, and 4",
                "description": "ORR in Cohorts 2, 3, and 4 will be calculated as the number of subjects whose best response is CR or PR, divided by the total number of subjects evaluable for ORR analysis.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to approximately 1 year",
                "name": "Phase 2: Overall survival (OS)",
                "description": "OS is defined as the time from the date of first dose to date of death due to any cause",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to approximately 1 year",
                "name": "Phase 2: Progression free survival (PFS)",
                "description": "PFS is defined as the time from date of the first dose until the earliest date of disease progression or death from any cause, whichever comes first",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From the date of the first dose until 30 days after discontinuation of study treatment, an average of 6 months to 1 year",
                "name": "Phase 2: Safety profile of ASTX295",
                "description": "Incidence and severity of adverse events (AEs) including serious adverse events (SAEs)",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I_II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 1,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03975387",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ACTFS Gene Amplification",
                    "Double Minute 2 Homolog Gene Amplification",
                    "HDMX Gene Amplification",
                    "MDM2 Proto-Oncogene Gene Amplification",
                    "MDM2 Proto-Oncogene, E3 Ubiquitin Protein Ligase Gene Amplification",
                    "Mouse Double Minute 2 Gene Amplification",
                    "Mouse Double Minute 2 Homolog Gene Amplification",
                    "hdm2 Gene Amplification"
                ],
                "nci_thesaurus_concept_id": "C36681",
                "name": "MDM2 Gene Amplification",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C36327",
                    "C21281",
                    "C3910",
                    "C25870",
                    "C97926",
                    "C18345",
                    "C45581",
                    "C36391",
                    "C36344",
                    "C133710"
                ],
                "parents": [
                    "C18345",
                    "C36344",
                    "C45581"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "CDKN2A",
                    "Cyclin-Dependent Kinase Inhibitor 2A Gene"
                ],
                "nci_thesaurus_concept_id": "C18022",
                "name": "CDKN2A Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C18593",
                    "C16612",
                    "C20917"
                ],
                "parents": [
                    "C18593"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Anomaly",
                    "DNA Sequence Variation",
                    "Genetic Abnormality",
                    "Genetic Alteration",
                    "Genetic Anomaly",
                    "Molecular Abnormality",
                    "Molecular Anomaly",
                    "Molecular Genetic Abnormality",
                    "Molecular Genetic Anomaly"
                ],
                "nci_thesaurus_concept_id": "C36391",
                "name": "Molecular Genetic Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C97926",
                    "C3910"
                ],
                "parents": [
                    "C97926"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "CDKN2A Loss",
                    "CDKN2A Null",
                    "Cyclin-Dependent Kinase 4 Inhibitor A Negative",
                    "Cyclin-Dependent Kinase Inhibitor 2A Negative",
                    "Cyclin-Dependent Kinase Inhibitor 2A Null"
                ],
                "nci_thesaurus_concept_id": "C131787",
                "name": "CDKN2A Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C18593",
                    "C20917",
                    "C77140",
                    "C165233",
                    "C16612",
                    "C3367",
                    "C18022",
                    "C35681"
                ],
                "parents": [
                    "C165233",
                    "C18022"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "P53",
                    "TP53",
                    "Tumor Protein P53 (Li-Fraumeni Syndrome) Gene"
                ],
                "nci_thesaurus_concept_id": "C17359",
                "name": "TP53 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C20917"
                ],
                "parents": [
                    "C20917"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Chromosomal, Gene, or Protein Abnormality",
                    "Cytogenetic or Molecular Genetic Abnormality",
                    "Genetic Abnormality",
                    "MOLECULAR_ABNORMALITY",
                    "Molecular Alteration"
                ],
                "nci_thesaurus_concept_id": "C3910",
                "name": "Molecular Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Negative"
                ],
                "nci_thesaurus_concept_id": "C35681",
                "name": "Negative Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "E3 Ubiquitin-Transferase Gene"
                ],
                "nci_thesaurus_concept_id": "C133710",
                "name": "Ubiquitin-Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "BCC7",
                    "FLJ92943",
                    "LFS1",
                    "TP53",
                    "TRP53",
                    "Tumor Protein P53 (Li-Fraumeni Syndrome) wt Allele",
                    "Tumor Protein p53 Gene",
                    "p53",
                    "p53 gene",
                    "p53 wild type"
                ],
                "nci_thesaurus_concept_id": "C52271",
                "name": "TP53 wt Allele",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C17359",
                    "C20917"
                ],
                "parents": [
                    "C17359"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Absent",
                    "LOST",
                    "Loss of Expression",
                    "Negative",
                    "Not Expressed"
                ],
                "nci_thesaurus_concept_id": "C165233",
                "name": "Expression Negative",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C35681",
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C35681"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Amplification",
                    "Gene Amplification"
                ],
                "nci_thesaurus_concept_id": "C45581",
                "name": "Gene Amplification Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C97926",
                    "C36327",
                    "C36391",
                    "C3910"
                ],
                "parents": [
                    "C36327"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "MDM2",
                    "MDM2 Proto-Oncogene Gene"
                ],
                "nci_thesaurus_concept_id": "C18345",
                "name": "MDM2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281",
                    "C133710"
                ],
                "parents": [
                    "C133710"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "VARIANT_TYPE",
                    "molecular consequence",
                    "molecular_consequence"
                ],
                "nci_thesaurus_concept_id": "C97926",
                "name": "Molecular Sequence Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3910"
                ],
                "parents": [
                    "C3910"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Gene Deregulation"
                ],
                "nci_thesaurus_concept_id": "C36344",
                "name": "Oncogene Deregulation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C97926",
                    "C36391",
                    "C36327",
                    "C3910"
                ],
                "parents": [
                    "C36327"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20917",
                "name": "Cell Cycle Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "CDK Inhibitor Gene",
                    "Cyclin Dependent Kinase Inhibitor Gene"
                ],
                "nci_thesaurus_concept_id": "C18593",
                "name": "Cyclin-Dependent Kinase Inhibitor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C20917"
                ],
                "parents": [
                    "C20917"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36327",
                "name": "Gene Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C36391",
                    "C97926",
                    "C3910"
                ],
                "parents": [
                    "C36391"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2021-08-11",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Malignant Solid Neoplasm",
                    "Recurrent Solid Neoplasm",
                    "Relapsed Solid Tumor",
                    "Recurrent Solid Tumor",
                    "Relapsed Malignant Solid Neoplasm",
                    "Relapsed Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127153",
                "name": "Recurrent Malignant Solid Tumor",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C132146",
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Solid Tumor",
                    "Metastatic Tumor",
                    "Metastatic Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Malignant Solid Neoplasm",
                    "Advanced Non-Hematologic Malignancy",
                    "Advanced Solid Neoplasm",
                    "Advanced Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C129707",
                "name": "Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C127155",
                    "C9270"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C133737",
                "name": "Refractory Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C120186",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Pleural Malignant Mesothelioma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C136403",
                "name": "Stage III Pleural Malignant Mesothelioma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136399"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIA Pleural Malignant Mesothelioma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C136404",
                "name": "Stage IIIA Pleural Malignant Mesothelioma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136403"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIB Pleural Malignant Mesothelioma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C136405",
                "name": "Stage IIIB Pleural Malignant Mesothelioma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136403"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Pleural Malignant Mesothelioma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C136406",
                "name": "Stage IV Pleural Malignant Mesothelioma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136399"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C148036",
                "name": "Unresectable Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27359",
                    "C132146",
                    "C127156"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148301",
                "name": "Refractory Sarcoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C120186",
                    "C9118"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148302",
                "name": "Recurrent Sarcoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813",
                    "C9118"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148331",
                "name": "Unresectable Sarcoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27359",
                    "C9118"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C152076",
                "name": "Metastatic Sarcoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9118",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153185",
                "name": "Advanced Sarcoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C152076",
                    "C9270"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C154444",
                "name": "Unresectable Pleural Malignant Mesothelioma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C179420",
                    "C7376",
                    "C154443"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C159675",
                "name": "Refractory Pleural Malignant Mesothelioma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7376",
                    "C150535"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C168545",
                "name": "Metastatic Pleural Malignant Mesothelioma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C165252",
                    "C7376"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Pleural Mesothelioma, Advanced",
                    "Advanced Malignant Mesothelioma of the Pleura",
                    "Advanced Malignant Mesothelioma of Pleura"
                ],
                "nci_thesaurus_concept_id": "C8706",
                "name": "Advanced Pleural Malignant Mesothelioma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C176863",
                    "C168545",
                    "C7865"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Relapsed Malignant Pleural Mesothelioma",
                    "Malignant Pleural Mesothelioma Recurrent",
                    "Relapsed Malignant Mesothelioma of the Pleura",
                    "Relapsed Malignant Mesothelioma of Pleura"
                ],
                "nci_thesaurus_concept_id": "C8707",
                "name": "Recurrent Pleural Malignant Mesothelioma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7866",
                    "C7376"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Tumour",
                    "Solid tumor, NOS",
                    "Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Tumor"
                ],
                "nci_thesaurus_concept_id": "C7628",
                "name": "Refractory Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C176863",
                "name": "Advanced Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9270",
                    "C176862"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent",
                    "Recurrent Tumor",
                    "Neoplasm Recurrence"
                ],
                "nci_thesaurus_concept_id": "C4798",
                "name": "Recurrent Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Sarcoma, Not Otherwise Specified",
                    "Sarcoma, NOS",
                    "Mesenchymal Tumor, Malignant",
                    "SARCOMA, MALIGNANT",
                    "SAR",
                    "Sarcoma of the Soft Tissue and Bone",
                    "Sarcoma of Soft Tissue and Bone"
                ],
                "nci_thesaurus_concept_id": "C9118",
                "name": "Sarcoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3810",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Mesothelioma, NOS"
                ],
                "nci_thesaurus_concept_id": "C3234",
                "name": "Mesothelioma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3786"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Connective and Soft Tissue Disease",
                    "Connective and Soft Tissue Diseases"
                ],
                "nci_thesaurus_concept_id": "C27574",
                "name": "Connective and Soft Tissue Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent Cancer",
                    "Recurrent Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C4813",
                "name": "Recurrent Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9305",
                    "C4798"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C179420",
                "name": "Unresectable Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3576",
                    "C27359"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Respiratory and Thoracic Disease",
                    "Respiratory, Thoracic, and Mediastinal Disease",
                    "Respiratory, Thoracic, and Mediastinal Disorder"
                ],
                "nci_thesaurus_concept_id": "C27669",
                "name": "Respiratory and Thoracic Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "resistant cancer",
                    "Refractory Cancer",
                    "clinical resistance"
                ],
                "nci_thesaurus_concept_id": "C120186",
                "name": "Refractory Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7628"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of the Pleura",
                    "Neoplasm of Pleura",
                    "Pleural Tumor",
                    "Neoplasm of the Pleura",
                    "Tumor of Pleura"
                ],
                "nci_thesaurus_concept_id": "C3332",
                "name": "Pleural Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3406",
                    "C26859"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Tumor of the Pleura",
                    "Malignant Tumor of Pleura",
                    "Malignant Neoplasm of Pleura",
                    "Malignant Neoplasm of the Pleura",
                    "Pleural Cancer",
                    "Cancer of the Pleura",
                    "Cancer of Pleura",
                    "Malignant Pleural Tumor"
                ],
                "nci_thesaurus_concept_id": "C3547",
                "name": "Malignant Pleural Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3576",
                    "C3332"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7865",
                "name": "Advanced Malignant Mesothelioma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C165252",
                    "C9270"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Thoracic Disease"
                ],
                "nci_thesaurus_concept_id": "C35742",
                "name": "Thoracic Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27669"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165252",
                "name": "Metastatic Malignant Mesothelioma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4456",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127156",
                "name": "Unresectable Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C150535",
                "name": "Refractory Malignant Mesothelioma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4456",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Pleural Disorders",
                    "Pleural Disease"
                ],
                "nci_thesaurus_concept_id": "C26859",
                "name": "Pleural Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C35742"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Mesothelioma Malignant Recurrent",
                    "Relapsed Malignant Mesothelioma"
                ],
                "nci_thesaurus_concept_id": "C7866",
                "name": "Recurrent Malignant Mesothelioma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4456",
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Neoplasm of Thorax",
                    "Malignant Tumor of Thorax",
                    "Malignant Neoplasm of the Thorax",
                    "Malignant Tumor of the Thorax",
                    "Malignant Thoracic Tumor"
                ],
                "nci_thesaurus_concept_id": "C3576",
                "name": "Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3406",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Mesothelioma, malignant",
                    "Malignant Tumor of Mesothelium",
                    "Malignant Tumor of the Mesothelium",
                    "Malignant Neoplasm of the Mesothelium",
                    "Malignant Mesothelial Neoplasm",
                    "Malignant Mesothelial Tumor",
                    "Malignant Neoplasm of Mesothelium"
                ],
                "nci_thesaurus_concept_id": "C4456",
                "name": "Malignant Mesothelioma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3234",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C154443",
                "name": "Unresectable Malignant Mesothelioma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27359",
                    "C4456"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm of Skeletal and Soft Tissue",
                    "Tumor of Skeletal and Soft Tissue",
                    "Neoplasm of Soft Tissue and Skeleton",
                    "Musculoskeletal and Soft Tissue Neoplasm",
                    "Skeletal and Soft Tissue Neoplasm",
                    "Soft Tissue and Bone Tumor",
                    "Neoplasm of Soft Tissue and Bone",
                    "Connective and Soft Tissue Tumor",
                    "Soft Tissue and Bone Neoplasm",
                    "Skeletal and Soft Tissue Tumor",
                    "Tumor of Soft Tissue and Skeleton",
                    "Tumor of Soft Tissue and Bone",
                    "Musculoskeletal and Soft Tissue Tumor"
                ],
                "nci_thesaurus_concept_id": "C3810",
                "name": "Connective and Soft Tissue Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27574",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Mesothelioma of Pleura",
                    "Malignant Pleural Mesothelioma",
                    "Malignant Mesothelioma of the Pleura",
                    "Pleural Diffuse Malignant Mesothelioma"
                ],
                "nci_thesaurus_concept_id": "C7376",
                "name": "Pleural Malignant Mesothelioma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3547",
                    "C4456",
                    "C9351"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C136399",
                "name": "Pleural Malignant Mesothelioma by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7376"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C27359",
                "name": "Unresectable Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C176862",
                "name": "Metastatic Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3576",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Mesothelial Neoplasms",
                    "Mesothelial Tumor"
                ],
                "nci_thesaurus_concept_id": "C3786",
                "name": "Mesothelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Mesothelioma of Pleura",
                    "Mesothelioma of the Pleura"
                ],
                "nci_thesaurus_concept_id": "C9351",
                "name": "Pleural Mesothelioma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3234",
                    "C3332"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Thoracic Tumor",
                    "Neoplasm of Thorax",
                    "Tumor of Thorax",
                    "Neoplasm of the Thorax",
                    "Tumor of the Thorax"
                ],
                "nci_thesaurus_concept_id": "C3406",
                "name": "Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C35742"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "ASTX295-01",
        "active_sites_count": 5,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacologic Agent",
                            "Pharmaceuticals",
                            "Agent",
                            "Pharmacological Substance",
                            "Pharmaceutical Agent",
                            "Drug Substance",
                            "Drug"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs",
                            "Anti-Tumor Agents",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C162749",
                        "name": "MDM2 Antagonist ASTX295",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C162996"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "p53-HDM2 Interaction Inhibitor",
                            "HDM2 Inhibitor",
                            "MDM2/MDMX Inhibitor",
                            "p53/MDM2 Interaction Inhibitor",
                            "MDM2-p53 Interaction Inhibitor",
                            "HDM2-p53 Interaction Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C162996",
                        "name": "MDM2 Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129839"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Apoptotic Pathway-targeting Cancer Therapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129839",
                        "name": "Apoptotic Pathway-targeting Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "ASTX295",
                "description": null,
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2019-05417",
        "why_study_stopped": null,
        "brief_summary": "Study ASTX295-01 is a first in human Phase 1/2 open-label study of the safety,\r\n      pharmacokinetics, and preliminary activity of ASTX295 in subjects with wild-type TP53\r\n      advanced solid tumors. Phase 1 is a dose escalation and dose expansion study design followed\r\n      by a Phase 2 study.",
        "brief_title": "Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53",
        "status_history": [
            {
                "status_date": "2021-08-11T00:00:00.000004",
                "status": "ACTIVE"
            },
            {
                "status_date": "2021-06-14T00:00:00.000003",
                "status": "TEMPORARILY_CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2020-05-27T00:00:00.000002",
                "status": "ACTIVE"
            },
            {
                "status_date": "2020-03-18T00:00:00.000001",
                "status": "TEMPORARILY_CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2019-07-11T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 191,
        "_current_trial_status_sort_order": 0,
        "start_date": "2019-07-11",
        "record_verification_date": "2022-01-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "NA"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2023-05-27",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]